VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs

Por Schub, David, Assmann, Gunter, Sester, Urban, Sester, Martina, Schmidt, Tina
Publicado no Arthritis Res Ther (2018)

Analysis of pramipexole dose–response relationships in Parkinson’s disease

Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)

T-bet expression in rheumatoid arthritis patients with early, disease-modifying anti-rheumatic drug...

Por Ponchel, F, Brown, AK, Field, SL, Quinn, M, Conaghan, P, Emery, P, Isaacs, JD
Publicado em 2005

Drug development in Alzheimer’s disease: the path to 2025

Por Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip
Publicado no Alzheimers Res Ther (2016)

Significance of measurement of serum trough level and anti‐drug antibody of adalimumab...

Por Nakase, H., Motoya, S., Matsumoto, T., Watanabe, K., Hisamatsu, T., Yoshimura, N., Ishida, T., Kato, S., Nakagawa, T., Esaki, M., Nagahori, M., Matsui, T., Naito, Y., Kanai, T., Suzuki, Y., Nojima, M., Watanabe, M., Hibi, T., Andoh, Akira, Ashida, Toshifumi, Endo, Katsuya, Endo, Yutaka, Esaki, Motohiro, Fujita, Hiroshi, Fujiya, Mikihiro, Haruma, Ken, Hibi, Toshifumi, Hiraoka, Sakiko, Hirata, Ichiro, Hisamatsu, Tadakazu, Honda, Yutaka, Iijima, Hideki, Iizuka, Bunei, Ikeya, Kentaro, Inoue, Takuya, Inoue, Shuji, Ishida, Tetsuya, Ishiguro, Yo, Ishihara, Shunji, Ito, Hiroaki, Iwakiri, Ryuichi, Kagaya, Takashi, Kanai, Takanori, Kashida, Hiroshi, Kato, Shingo, Kato, Jun, Katsurada, Takehiko, Kinjyo, Fukunori, Kobayashi, Kiyonori, Kodama, Mayumi, Kunisaki, Reiko, Kurahara, Koichi, Kurokami, Takafumi, Kyouwon, Lee, Matsuda, Koichiro, Matsueda, Kazuhiro, Matsui, Toshiyuki, Matsumoto, Takayuki, Mitsuyama, Keiichi, Mizokami, Yuji, Motoya, Satoshi, Naito, Yuji, Nakagawa, Tomoo, Nakamura, Shiro, Nakase, Hiroshi, Nojima, Masanori, Nomura, Masafumi, Ogawa, Atsuhiro, Okazaki, Kazuichi, Otsuka, Kazuaki, Sakuraba, Hirotake, Saruta, Masayuki, Sasaki, Makoto, Shirai, Takayuki, Suga, Tomoaki, Sugimura, Kazuhito, Sugiyama, Toshiro, Suzuki, Yasuo, Takeshima, Fuminao, Tamaki, Hiroyuki, Tanaka, Shinji, Tanida, Satoshi, Tominaga, Keiichi, Tomizawa, Taku, Watanabe, Kenji, Watanabe, Mamoru, Yamamoto, Shojiro, Yamashita, Masaki, Yoshida, Atsushi, Yoshimura, Naoki
Publicado no Aliment Pharmacol Ther (2017)

Effects of Diacerein at the Molecular Level in the Osteoarthritis Disease Process

Por Martel-Pelletier, Johanne, Pelletier, Jean-Pierre
Publicado em 2010

<i>NAT2</i> gene polymorphism and development of multiple drug resistant tuberculosis in patients with HIV infection

Por N. V. Maltseva, I. B. Viktorova, O. M. Kazantseva, A. L. Khanin
Publicado em 2021-11-01

Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease

Por Bradbury, Allison, Bagel, Jessica, Sampson, Maureen, Farhat, Nicole, Ding, Wenge, Swain, Gary, Prociuk, Maria, O’Donnell, Patricia, Drobatz, Kenneth, Gurda, Brittney, Wassif, Christopher, Remaley, Alan, Porter, Forbes, Vite, Charles
Publicado no J Pharmacol Exp Ther (2016)

Albumin-based drug delivery: harnessing nature to cure disease

Por Larsen, Maja Thim, Kuhlmann, Matthias, Hvam, Michael Lykke, Howard, Kenneth A.
Publicado no Mol Cell Ther (2016)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease

Por Vassar, Robert
Publicado no Alzheimers Res Ther (2014)

Predicting relapse of Graves' disease following treatment with antithyroid drugs

Por LIU, LIN, LU, HONGWEN, LIU, YANG, LIU, CHANGSHAN, XUN, CHU
Publicado no Exp Ther Med (2016)

Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs

Por Bugatti, Serena, Manzo, Antonio, Benaglio, Francesca, Klersy, Catherine, Vitolo, Barbara, Todoerti, Monica, Sakellariou, Garifallia, Montecucco, Carlomaurizio, Caporali, Roberto
Publicado em 2012

Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease

Por Pasma, Annelieke, Schenk, Charlotte V., Timman, Reinier, Busschbach, Jan J. V., van den Bemt, Bart J.F., Molenaar, Esmeralda, van der Laan, Willemijn H., Schrauwen, Saskia, van’t Spijker, Adriaan, Hazes, Johanna M. W.
Publicado no Arthritis Res Ther (2015)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease

Por Simsek, Melek, Meijer, Berrie, Mulder, Chris J. J., van Bodegraven, Adriaan A., de Boer, Nanne K. H.
Publicado no Ther Drug Monit (2017)

Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development

Por Nordberg, Agneta
Publicado em 2011

Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients

Por de Bandt, Michel, Fautrel, Bruno, Maillefert, Jean Francis, Berthelot, Jean Marie, Combe, Bernard, Flipo, René-Marc, Lioté, Frédéric, Meyer, Olivier, Saraux, Alain, Wendling, Daniel, Le Loët, Xavier, Guillemin, Francis
Publicado em 2009

Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

Por van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Publicado no Rheumatol Ther (2018)

Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer’s Disease and Related...

Por Kovalevich, Jane, Cornec, Anne-Sophie, Yao, Yuemang, James, Michael, Crowe, Alexander, Lee, Virginia M.-Y., Trojanowski, John Q., Smith, Amos B., Ballatore, Carlo, Brunden, Kurt R.
Publicado no J Pharmacol Exp Ther (2016)

Effects of donepezil on cognitive functions and the expression level of β-amyloid in peripheral blood of patients with Alzheimer's disease

Por Ma, Yunxia, Ji, Jinming, Li, Gang, Yang, Shuzhen, Pan, Shuangshuang
Publicado no Exp Ther Med (2018)

Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan

Por Al-Azzam, Sayer I, Alzoubi, Karem H, AbuRuz, Salah, Alefan, Qais
Publicado no Ther Clin Risk Manag (2016)